Cohesic COO, Dr. Christine Lorenz, named Fellow of American Institute of Medical and Biological Engineering< Back To Feed
On February 18, 2022, it was announced that Dr. Christine Lorenz, Cohesic Chief Operating Officer has been elected to the College of Fellows of the American Institute of Medical and Biological Engineering (AIMBE). The AIMBE College of Fellows is comprised of the top 2% of medical and biological engineers who are regularly recognized for contributions in teaching, research, and innovation.
Christine has spent her career at the intersection of health care delivery and innovation, always focusing on how technology can be effectively translated from academia to industry to the clinical setting to have a positive impact on medicine and healthcare. Indeed, Christine was nominated, reviewed, and elected by peers and members of the AIMBE College of Fellows for outstanding contributions to biomedical technology commercialization through cultivating relationships between industry and academics.
Christine joined Cohesic in 2019 because she believes that Cohesic's innovations will have a significant positive impact for patients with cardiovascular disease and for the broader healthcare system as a whole. This certainly aligns with the mission of AIMBE to “advocate for the fields of medical and biological engineering to advance society.”
Everyone at Cohesic congratulates Christine on this recognition for her work, and we join with her in continuing to bring innovation into clinical care that benefit patients and society.
Read more about Christine and the award in the press release here, and also on the Washington University (McKelvey School of Engineering) website: https://engineering.wustl.edu/news/2022/Three-Washington-University-faculty-alumna-named-AIMBE-Fellows.html.